From: The paradox of ventilator-associated pneumonia prevention measures
Impact on | ||||||
---|---|---|---|---|---|---|
Subjects | VAP rates | Ventilator LOS | ICU LOS | Hospital LOS | Mortality | |
Elevation of the head of the bed | ||||||
Drakulovic, et al., 1999 [5] | 86 | 78% ↓ | NS | NS | - | NS |
van Nieuwenhoven, et al., 2006 [46] | 221 | NS | NS | NS | - | NS |
Oral care | ||||||
Chlorhexidine | ||||||
DeRiso, et al., 1996 [40] | 353 | NS | NS | - | NS | 80% ↓ |
Fourrier, et al., 2000 [1] | 60 | 66% ↓ | NS | NS | - | NS |
Genuit, et al., 2001 [2] | 95 | 37% ↓ | NS | NS | NS | - |
Houston, et al., 2002 [47] | 561 | NS | NS | - | - | - |
Fourrier, et al., 2005 [48] | 228 | NS | NS | NS | - | NS |
Koeman, et al., 2006 [3] | 257 | NS | NS | NS | NS | NS |
Segers, et al., 2006 [49] | 954 | 50% ↓ | - | NS | 8% ↓ | NS |
Tantipong, et al., 2008 [50] | 207 | NS | - | - | - | NS |
Chan, et al., 2007 [4] (meta-analysis) | 2,144 | 44% ↓ | NS | NS | - | NS |
Oral topical antibiotics | ||||||
Laggner, et al., 1994 [51] (gentamicin) | 67 | NS | NS | - | - | NS |
Bergmans, et al., 2001 [52] (gentamicin, colistin, vancomycin) | 226 | 57%-68% ↓ | NS | NS | NS | NS |
Kollef, et al., 2006 [53] (iseganan) | 709 | NS | - | - | - | NS |
Chan, et al., 2007 [4] (meta-analysis) | 1,098 | NS | NS | NS | - | NS |
de Smet, et al., 2009 [31] (tobramycin, colistin, amphotericin B) | 3,894 | - | NS | NS | NS | 14% ↓ |
Deep vein thrombosis prophylaxis | ||||||
Samama, et al., 1999 [54] | 1,102 | - | - | - | - | NS |
Fraisse, et al., 2000 [55] | 223 | - | - | - | - | NS |
Leizorovicz, et al., 2004 [56] | 3,706 | - | - | - | - | NS |
Mahé, et al., 2005 [57] | 2,474 | - | - | - | - | NS |
Stress ulcer prophylaxis | ||||||
Prod'hom, et al., 1994 [58] | 248 | NS | - | - | - | NS |
Bonten, et al., 1995 [59] | 141 | NS | - | - | NS | NS |
Yildizdas, et al., 2002 [60] | 160 | NS | - | - | - | NS |
Kantorova, et al., 2004 [61] | 287 | NS | NS | NS | - | NS |
Cook, et al., 1996 [10] (meta-analysis) | 7,218 | NS | - | - | - | NS |
Continuous aspiration of subglottic secretions | ||||||
Valles, et al., 1995 [6] | 153 | 37% ↓ | - | NS | - | NS |
Kollef, et al., 1999 [62] | 343 | 39% ↓ | NS | NS | NS | NS |
Smulders, et al., 2002 [63] | 150 | 75% ↓ | NS | NS | NS | NS |
Lorente, et al., 2007 [64] | 280 | 64% ↓ | NS | NS | - | NS |
Bouza, et al., 2008 [39] | 690 | NS | NS | NS | NS | NS |
Silver-coated endotracheal tubes | ||||||
Kollef, et al., 2008 [8] | 2,003 | 36% ↓ | NS | NS | NS | NS |